GlassScriptPhysician profile
Richard J Madonna
NPI 1194798637
$75,081.76
in general payments reported to CMS, 2019-2025
15 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $14K · 2021: $4,621 · 2022: $13K · 2023: $414 · 2024: $1,426 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Travel and Lodging: $1,928 · Food and Beverage: $1,273 · Consulting Fee: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,000.00 |
| Travel and Lodging | $1,928.15 |
| Food and Beverage | $1,273.01 |
| Consulting Fee | $1,170.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $22,346.12 | 2022-2025 | Vyzulta, Miebo |
| Aerie Pharmaceuticals, INC. | $21,241.93 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $12,510.91 | 2019-2022 | |
| Allergan, INC. | $9,697.40 | 2019-2021 | |
| Alcon Vision LLC | $3,674.67 | 2022-2025 | Rocklatan, Rhopressa, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,224.78 | 2019-2021 | |
| Dompe US, INC. | $1,648.86 | 2021-2023 | Oxervate |
| Glaukos Corporation | $904.33 | 2019-2025 | Radius, Istent Infinite |
| Topcon Healthcare, INC. | $370.64 | 2022-2024 | |
| Eyevance Pharmaceuticals LLC | $185.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $118.61 | 2019-2022 | |
| Genzyme Corporation | $49.53 | 2019-2024 | |
| Abbvie INC. | $38.57 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $37.24 | 2019 | |
| Quidel Corporation | $33.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Madonna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.